Drug Trial Radar · NCT05391893
Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
Last checked: Nov 19, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
444
Actual
Start
Jun 19, 2020
Primary completion
Apr 1, 2023
Study completion Apr 1, 2023
Sponsor
- Lead sponsor
- Corewell Health SouthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 26, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to reduce hospital admission and decrease time to disposition through establishing an effective treatment protocol for AF and Atrial Flutter in the Emergency Department of Spectrum Health Lakeland. Secondary outcome is to measure if oral diltiazem is an effective HR controlling agent in AF RVR and Flutter.
Conditions
- Atrial Fibrillation
- Atrial Flutter
Interventions
OralDrug
Diltiazem 0.25mg/kg injection, give over 2 minutes, max dose 30mg
Intravenous drugDrug
these patients will receive traditional treatments at provider discretion. They must receive at least one intravenous medication for atrial fibrillation with rapid ventricular response. This will be a heterogenous group of patients receiving digoxin, amiodarone, various beta-blockers, and intravenous diltiazem without oral diltiazem.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Admission RateTime frame: 1 days
- Treatment Success at 3 HoursTime frame: 3 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Matthew Hysell
Saint Joseph, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.